Needle Biopsy Market Research Report- Forecast till 2030

Needle Biopsy Market Share, Growth And Trends Analysis By Type (Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy) Utility (Disposable, Reusable), Applications (Tumor, Infection, Inflammation, Others) - Forecast Till 2030

ID: MRFR/MED/2542-HCR | 110 Pages | Published By Kinjoll Dey on April 2023         

Table of Contents

1. INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2. RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3. MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4. MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

5. GLOBAL NEEDLE BIOPSY MARKET, BY TYPE

5.1 FINE-NEEDLE ASPIRATION BIOPSY

5.2 CORE NEEDLE BIOPSY

5.3 VACUUM-ASSISTED BIOPSY

5.4 IMAGE-GUIDED BIOPSY

6. GLOBAL NEEDLE BIOPSY MARKET, BY UTILITY

6.1 DISPOSABLE

6.2 REUSABLE

7. GLOBAL NEEDLE BIOPSY MARKET, BY APPLICATIONS

7.1 TUMOR

7.2 INFECTION

7.3 INFLAMMATION

7.4 OTHERS

8. GLOBAL NEEDLE BIOPSY MARKET, BY REGION

8.1 NORTH AMERICA

8.1.1 INTRODUCTION

8.2 EUROPE

8.2.1 INTRODUCTION

8.3 ASIA-PACIFIC

8.3.1 INTRODUCTION

8.4 MIDDLE EAST & AFRICA

8.4.1 INTRODUCTION

9. COMPETITIVE LANDSCAPE

9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS

9.1.1 STRATEGIC PARTNERSHIP

9.1.2 MERGER & ACQUISITION

10. COMPANY PROFILE

10.1 BOSTON SCIENTIFIC CORPORATION

10.1.1 OVERVIEW

10.1.2 PRODUCT OVERVIEW

10.1.3 FINANCIALS

10.1.4 KEY DEVELOPMENTS

10.2 COOK MEDICAL

10.2.1 OVERVIEW

10.2.2 PRODUCT OVERVIEW

10.2.3 FINANCIALS

10.2.4 KEY DEVELOPMENTS

10.3 CAREFUSION CORPORATION

10.3.1 OVERVIEW

10.3.2 PRODUCT OVERVIEW

10.3.3 FINANCIALS

10.3.4 KEY DEVELOPMENT

10.4 HOLOGIC, INC.

10.4.1 OVERVIEW

10.4.2 PRODUCT OVERVIEW

10.4.3 FINANCIALS

10.4.4 KEY DEVELOPMENTS

10.5 CARDINAL HEALTH, INC.

10.5.1 OVERVIEW

10.5.2 PRODUCT OVERVIEW

10.5.3 FINANCIALS

10.5.4 KEY DEVELOPMENTS

10.6 MEDAX

10.6.1 OVERVIEW

10.6.2 PRODUCT OVERVIEW

10.6.3 FINANCIALS

10.6.4 KEY DEVELOPMENTS

10.7 C. R. BARD

10.7.1 OVERVIEW

10.7.2 PRODUCT OVERVIEW

10.7.3 FINANCIALS

10.7.4 KEY DEVELOPMENTS

10.8 MÖLLER MEDICAL GMBH

10.8.1 OVERVIEW

10.8.2 PRODUCT OVERVIEW

10.8.3 FINANCIALS

10.8.4 KEY DEVELOPMENTS

10.10 BECTON, DICKINSON AND COMPANY

10.10.1 OVERVIEW

10.10.2 PRODUCT OVERVIEW

10.10.3 FINANCIALS

10.10.4 KEY DEVELOPMENTS

10.10 HAKKO CO. LTD.

10.10.1 OVERVIEW

10.10.2 PRODUCT OVERVIEW

10.10.3 FINANCIALS

10.10.4 KEY DEVELOPMENTS

10.11 KOMPASS

10.11.1 OVERVIEW

10.11.2 PRODUCT OVERVIEW

10.11.3 FINANCIALS

10.11.4 KEY DEVELOPMENTS

10.12 OTHERS

CONCLUSION

11.1 KEY FINDINGS

11.1.1 FROM CEO’S VIEWPOINT

11.1.2 UNMET NEEDS OF THE MARKET

11.2 KEY COMPANIES TO WATCH

11.3 PREDICTION OF NEEDLE BIOPSY INDUSTRY

12. APPENDIX